Skip to main content
Clinical Trials/NCT00010608
NCT00010608
Completed
Phase 2

Clinical Trial of Meditation for Cardiovascular Disease in Older Black Women

National Center for Complementary and Integrative Health (NCCIH)3 sites in 1 country196 target enrollmentOctober 1999

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Cardiovascular Diseases
Sponsor
National Center for Complementary and Integrative Health (NCCIH)
Enrollment
196
Locations
3
Primary Endpoint
Carotid artery atherosclerosis (IMT) measured non-invasively by quantitative B-mode ultrasonography
Status
Completed
Last Updated
16 years ago

Overview

Brief Summary

The purpose of this study is to evaluate the effectiveness of meditation in preventing of atherosclerotic cardiovascular disease (CVD) in postmenopausal, older African American women.

Detailed Description

Older African American women suffer from disproportionately high rates of cardiovascular (CVD) morbidity and mortality compared to white Americans. Numerous controlled studies suggest that this disparity is associated with chronic psychosocial and environmental stress. Research indicates that Transcendental Meditation (TM) may result in significant improvements in CVD risk factors in this high risk population. Participants in this study will be randomly assigned to either active stress reduction with TM or health education control, both in addition to usual medical care, for 12 months. The primary outcome will be carotid artery atherosclerosis (IMT) measured non-invasively by quantitative B-mode ultrasonography. Secondary measures will include traditional CVD risk factors (blood pressure, serum glucose and insulin levels, obesity, and sedentary lifestyle), stress-related neurohormones (catecholamine metabolite and cortisol), psychosocial stress, and quality of life. The results of this trial will yield valuable new knowledge for the prevention of CVD through a CAM intervention in high risk older African American women.

Registry
clinicaltrials.gov
Start Date
October 1999
End Date
July 2006
Last Updated
16 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • African American, self-identified
  • Coronary artery disease (CAD/CHD) defined by laboratory examination or documented clinical history of: a)myocardial infarction; b) coronary revascularization procedure--CABG, PTCA; c) coronary angiography--at least one coronary artery with \>50% stenosis
  • Informed consent
  • Written Permission of participant's referring physician

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Carotid artery atherosclerosis (IMT) measured non-invasively by quantitative B-mode ultrasonography

Time Frame: one year

Study Sites (3)

Loading locations...

Similar Trials